Pfizer PFE
NYSE PFE
$28.27 +0.44 (+1.58%)
At close: Oct 9, 2026 · 4:00 PM EDT

Pfizer (PFE) Share-based Compensation (2009 - 2026)

Updated

Pfizer (PFE) posted Share-based Compensation of $249 million for Q2 2026, up 22.7% from $203 million a year earlier but down 8.5% from the prior quarter.

Analysis

Pfizer (PFE) Share-based Compensation (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 28, 2026, Share-based Compensation at Pfizer was $947 million, up 14.9% year-over-year; for FY2025, it was $799 million, down 8.9% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • In prior years, Pfizer's Share-based Compensation was $877 million in FY2024 (+67.0%), $525 million in FY2023 (-39.8%), $872 million in FY2022 (-26.2%) and $1.18 billion in FY2021 (+56.6%).
  • Quarterly Share-based Compensation has run from a low of $86 million in Q1 2022 to a high of $496 million in Q4 2021 over five years.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last three quarters, with growth averaging 15.0% over the last seven quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2024, with growth of 109.5%; the weakest was Q4 2023, with a decline of 66.8%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $272 million (Q1 2026), $225 million (Q4 2025) and $201 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 458.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 166.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 231.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 249.00 Mn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 170.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 249.00 Mn
Mar 29, 2026 272.00 Mn
Dec 31, 2025 225.00 Mn
Sep 28, 2025 201.00 Mn
Jun 29, 2025 203.00 Mn
Mar 30, 2025 170.00 Mn
Dec 31, 2024 177.00 Mn
Sep 29, 2024 274.00 Mn
Jun 30, 2024 206.00 Mn
Mar 31, 2024 220.00 Mn
Dec 31, 2023 121.00 Mn
Jul 2, 2023 148.00 Mn
Apr 2, 2023 105.00 Mn
Dec 31, 2022 364.00 Mn
Jul 3, 2022 287.00 Mn
Apr 3, 2022 86.00 Mn
Dec 31, 2021 496.00 Mn
Oct 3, 2021 293.00 Mn
Jul 4, 2021 221.00 Mn
Apr 4, 2021 172.00 Mn
API Access

Pfizer Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PFE&period=max&api_key=YOUR_API_KEY